APA (7th ed.) Citation

K, F., Y, O., M, H., R, A., T, O., A, S., . . . M, K. (2026). High E2F7 Expression Indicates Pancreatic Cancer Aggressiveness and Downregulation of E2F7 Enhances Sensitivity to S-1. Annals of surgical oncology, 33(6), 5429. https://doi.org/10.1245/s10434-025-18912-3

Chicago Style (17th ed.) Citation

K, Fujita, et al. "High E2F7 Expression Indicates Pancreatic Cancer Aggressiveness and Downregulation of E2F7 Enhances Sensitivity to S-1." Annals of Surgical Oncology 33, no. 6 (2026): 5429. https://doi.org/10.1245/s10434-025-18912-3.

MLA (9th ed.) Citation

K, Fujita, et al. "High E2F7 Expression Indicates Pancreatic Cancer Aggressiveness and Downregulation of E2F7 Enhances Sensitivity to S-1." Annals of Surgical Oncology, vol. 33, no. 6, 2026, p. 5429, https://doi.org/10.1245/s10434-025-18912-3.